Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
ADC Therapeutics logo

ADC Therapeutics

Recent Finacing

Equity

Recent Raise

$60M

ADC Therapeutics is a Lausanne-based biopharma company commercializing antibody–drug conjugates such as its FDA- and EMA-approved lymphoma therapy ZYNLONTA.

Vaud, Switzerland
251-500
Publicly Traded
adctherapeutics.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Medical
Therapeutics

Recent Investors

Auven Therapeutics logo
AstraZeneca logo
W
Redmile Group logo
Deerfield Management logo
TCGX logo
Overland Pharmaceuticals logo
MedImmune logo

Financials

$726M

Total Raised

8

Funding rounds

8

Investors


Team

Upgrade to view the team

See the team members at ADC Therapeutics.